<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/14111" />
  <subtitle />
  <id>http://localhost:80/xmlui/handle/123456789/14111</id>
  <updated>2026-04-12T01:10:13Z</updated>
  <dc:date>2026-04-12T01:10:13Z</dc:date>
  <entry>
    <title>SOLID DISPERSIONS: A REVIEW</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/14138" />
    <author>
      <name>K, DHIRENDRA</name>
    </author>
    <author>
      <name>S, LEWIS</name>
    </author>
    <author>
      <name>N, UDUPA</name>
    </author>
    <author>
      <name>K, ATIN</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/14138</id>
    <updated>2022-11-28T10:28:07Z</updated>
    <published>2009-04-20T00:00:00Z</published>
    <summary type="text">Title: SOLID DISPERSIONS: A REVIEW
Authors: K, DHIRENDRA; S, LEWIS; N, UDUPA; K, ATIN
Abstract: Solid dispersions have attracted considerable interest as an efficient means of improving the dissolution rate and hence the bioavailability of a range of hydrophobic drugs. This article reviews the various preparation&#xD;
techniques for solid dispersion and compiles some of the recent technology transfers. The different types of&#xD;
solid dispersions based on the molecular arrangement have been highlighted. Some of the practical aspects to&#xD;
be considered for the preparation of solid dispersions, such as selection of carrier and methods of&#xD;
physicochemical characterization, along with an insight into the molecular arrangement of drugs in solid&#xD;
dispersions are also discussed. Finally, an in-depth rationale for limited commercialization of solid dispersions&#xD;
and recent revival has been considered.</summary>
    <dc:date>2009-04-20T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>FREQUENCY OF ASPIRIN RESISTANCE IN PATIENTS WITH CORONORY ARTERY DISEASE IN PAKISTAN</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/14137" />
    <author>
      <name>AKHTAR, NAVEED</name>
    </author>
    <author>
      <name>JUNAID, AYESHA</name>
    </author>
    <author>
      <name>KHALID, AYESHA</name>
    </author>
    <author>
      <name>AHMED, WAQAS</name>
    </author>
    <author>
      <name>ALI SHAH, MUMTAZ</name>
    </author>
    <author>
      <name>UR RAHMAN, HABIB</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/14137</id>
    <updated>2022-11-28T10:25:28Z</updated>
    <published>2009-04-19T00:00:00Z</published>
    <summary type="text">Title: FREQUENCY OF ASPIRIN RESISTANCE IN PATIENTS WITH CORONORY ARTERY DISEASE IN PAKISTAN
Authors: AKHTAR, NAVEED; JUNAID, AYESHA; KHALID, AYESHA; AHMED, WAQAS; ALI SHAH, MUMTAZ; UR RAHMAN, HABIB
Abstract: Aspirin resistance is an emerging clinical entity. However the data available on aspirin resistance in Asian&#xD;
population is scarce. This study was initiated to prospectively evaluate the frequency of aspirin resistance in&#xD;
patients with stable coronary artery disease (CAD) in Pakistan. A cross sectional prospective study was&#xD;
conducted in cardiology and hematology departments at Shifa International Hospital, Islamabad from January to&#xD;
December 2007. Two hundred and fifty patients were enrolled from cardiology out patient department having&#xD;
met the specific inclusion criteria. Details were entered on a pre-designed questionnaire and aspirin response&#xD;
assay was performed on IMPACT–R (Dia Med AG 1785 Cressier Morat, Switzerland). Data was analyzed&#xD;
using SPSS V12. Aspirin resistance was observed in 12% of patients. 73.2% of study population were male and&#xD;
26.8% were female, with a mean age of 57.2 years. There was no significant correlation of aspirin resistance&#xD;
with traditional risk factors like Diabetes Mellitus (DM), Hypertension or Dyslipidemia. 84% of Aspirin non&#xD;
responders were taking 75mg per day and 16% were on 150mg per day. A positive trend was noted between&#xD;
aspirin resistance and cigarette smoking. Aspirin resistance is a real phenomenon in Pakistani population with&#xD;
an estimated frequency of 12%. Large scale prospective randomized trials with long term follow up are needed&#xD;
to assess the impact of different doses and the clinical significance of this biochemical entity.</summary>
    <dc:date>2009-04-19T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>QUALITY OF CEFTRIAXONE IN PAKISTAN: REALITY AND RESONANCE</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/14136" />
    <author>
      <name>ALI, OBAID</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/14136</id>
    <updated>2022-11-28T10:22:47Z</updated>
    <published>2009-04-18T00:00:00Z</published>
    <summary type="text">Title: QUALITY OF CEFTRIAXONE IN PAKISTAN: REALITY AND RESONANCE
Authors: ALI, OBAID
Abstract: The quality of pharmaceuticals is a global concern, counterfeit/ poor quality/ substandard medicines can cause&#xD;
harms in various ways: In a number of developing countries including Pakistan there is reportedly a high&#xD;
incidence of the availability of substandard drugs. The majority of these reports do not contain quantitative data&#xD;
to support these claims, nor do they describe the methodology employed for the quality assessment. Quality of&#xD;
drugs available in Pakistan are being questioned and topic of discussion in local news paper, TV channels in&#xD;
general public including journalist and physicians due to disparity of price among same generics, lack of&#xD;
knowledge for such science and unknown reasons. Since, quality of drugs can neither be assessed by naked eye&#xD;
or by every one therefore, randomly selected, 96 samples of different strength of Injection Ceftriaxone Sodium&#xD;
and its generic, a widely used third generation cephalosporin in Pakistan since 1982 and 1994 till date&#xD;
respectively included in the said study to know the reality. 15.62% of Ceftriaxone Injection was found to be Out&#xD;
of Specification, however, not a single sample was found fake (spurious) out of 96 tested samples. Nevertheless, quality is a wide ranging concept covering all matters that individually or collectively influence the excellence of a product hence price and other related issues are also analyzed in the study.</summary>
    <dc:date>2009-04-18T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>EFFECT OF HYDROPHILIC NATURAL GUMS IN FORMULATION OF ORAL-CONTROLLED RELEASE MATRIX TABLETS OF PROPRANOLOL HYDROCHLORIDE</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/14135" />
    <author>
      <name>RAJESH, KS</name>
    </author>
    <author>
      <name>VENKATARAJU, MP</name>
    </author>
    <author>
      <name>GOWDA, DV</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/14135</id>
    <updated>2022-11-28T10:19:00Z</updated>
    <published>2009-04-17T00:00:00Z</published>
    <summary type="text">Title: EFFECT OF HYDROPHILIC NATURAL GUMS IN FORMULATION OF ORAL-CONTROLLED RELEASE MATRIX TABLETS OF PROPRANOLOL HYDROCHLORIDE
Authors: RAJESH, KS; VENKATARAJU, MP; GOWDA, DV
Abstract: In order to develop a controlled delivery of highly water-soluble propranolol hydrochloride (PPHCl) using&#xD;
hydrophilic natural gums (xanthan gum [X] and locust bean gum [LBG]) as cost-effective, nontoxic, easily&#xD;
available. The granules of PPHCl were prepared by wet granulation method using a different ratios drug: gum&#xD;
ratios of X, LBG and XLBG(X and LBG in 1:1 ratios). To increase the flowability and compressibility of the&#xD;
granules, and to prevent its adhesion to punch and die, magnesium stearate and talc were added to the granules&#xD;
in 1:2 ratios before punching. The tablets was analysed to determine hardness, friability, % assay and invitro&#xD;
release study was carried out.&#xD;
The release of PPHCl from a gelatinous swollen mass, which controls the diffusion of drug molecules through&#xD;
the polymeric material into aqueous medium. The XLBG matrices shows precise controlled release than the X&#xD;
and LBG matrices because of burst effect and fast release in case of X and LBG matrices respectively and there&#xD;
was no chemical interaction between drug and polymers in XLBG formulation as confirmed by FTIR studies.&#xD;
First pass effect of PPHCl can be avoided by these formulations. Matrices with XLBG show zero-order release&#xD;
via swelling, diffusion and relaxation mechanism.&#xD;
The XLBG matrices leads to more precise result than X and LBG alone by the utilization of synergistic&#xD;
interaction between two biopolymers and uniformity in the hydration layer in dissolution media. However,&#xD;
according to the similarity factor (f2) XLBG3 were the most similar formulation to Lol-SR as the reference&#xD;
standard.</summary>
    <dc:date>2009-04-17T00:00:00Z</dc:date>
  </entry>
</feed>

